REQUEST A DEMO
Total
USD $0.00
Search more companies

Maharshi Badri Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Maharshi Badri Pharmaceuticals Private Limited Profile Updated: November 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Maharshi Badri Pharmaceuticals Private Limited is an unlisted company, incorporated on 09/04/2007. It has its registered office in the State of Rajasthan, India. Company's corporate identification number (CIN) is U24232RJ2007PTC024162 and registration number is 024162. The company is a manufacturing company, it is engaged in other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.

Legal Address
Vaid Bhawan, Shilp Colony, Khatipura Road, Jhotwara,
Jaipur; Rajasthan; Postal Code: 302012

Contact Details: Purchase the Maharshi Badri Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Maharshi Badri Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Maharshi Badri Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 09, 2007
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Small Shareholders Director
Company Performance
Financial values in the chart are available after Maharshi Badri Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
13.52%
Total operating revenue
13.52%
Operating profit (EBIT)
14.82%
EBITDA
-3.19%
Net Profit (Loss) for the Period
14.82%
Total assets
19.74%
Total equity
7.39%
Operating Profit Margin (ROS)
0.01%
Net Profit Margin
0.01%
Return on Equity (ROE)
0.97%
Debt to Equity Ratio
-0.46%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?